Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won’t have to raise medicine prices, as Trump’s new reciprocal tariffs on India exempt the pharmaceutical sector.

What Happened: While appearing on the Somebody’s Gotta Win With Tara Palmeri podcast earlier this week, Cuban stated that if the Trump administration imposes tariffs on India, his company would be compelled to raise the prices of its medications. “We won’t have a choice,” Cuban stated

Interestingly, U.S. President Donald Trump announced a 26% reciprocal tariff on India. The pharmaceutical industry, however, was exempted from these new levies, as per the fact sheet released by the White House on April 2.

Cost Plus Drugs did not immediately respond to Benzinga’s request for comment.

See Also: 

Full story available on Benzinga.com

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won’t have to raise medicine prices, as Trump’s new reciprocal tariffs on India exempt the pharmaceutical sector.

What Happened: While appearing on the Somebody’s Gotta Win With Tara Palmeri podcast earlier this week, Cuban stated that if the Trump administration imposes tariffs on India, his company would be compelled to raise the prices of its medications. “We won’t have a choice,” Cuban stated

Interestingly, U.S. President Donald Trump announced a 26% reciprocal tariff on India. The pharmaceutical industry, however, was exempted from these new levies, as per the fact sheet released by the White House on April 2.

Cost Plus Drugs did not immediately respond to Benzinga’s request for comment.

See Also: 

Full story available on Benzinga.com

 Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won’t have to raise medicine prices, as Trump’s new reciprocal tariffs on India exempt the pharmaceutical sector.
What Happened: While appearing on the Somebody’s Gotta Win With Tara Palmeri podcast earlier this week, Cuban stated that if the Trump administration imposes tariffs on India, his company would be compelled to raise the prices of its medications. “We won’t have a choice,” Cuban stated
Interestingly, U.S. President Donald Trump announced a 26% reciprocal tariff on India. The pharmaceutical industry, however, was exempted from these new levies, as per the fact sheet released by the White House on April 2.
Cost Plus Drugs did not immediately respond to Benzinga’s request for comment.
See Also: Full story available on Benzinga.com   Read Morebenzinga neuro, Donald Trump, Mark Cuban, News, tariffs, Trump Administration, Markets, News, Markets, Benzinga News